The EMAs drug safety committee (PRAC) launched a review of medicines containing semaglutide a GLP-1 agonist and the active ingredient in Novo Nordisk's Ozempic, Wegovy and Rybelsus in January, following concerns that the drugs could lead to an increased risk of developing non-arteritic anterior ischemic optic neuropathy (NAION)
Since many tirzepatide users already supplement with B12 , discuss any long-term acid suppression therapy with your healthcare provider to ensure nutrient status is monitored
Hydration strategy Reduced food intake means reduced water intake from food sources (food provides roughly 20% of your daily water)
Los pacientes con enfermedades arteriales perifricas que desarrollan claudicacin tienen importantes limitaciones al realizar ejercicios fsicos y tienen dificultades para caminar incluso a distancias cortas a velocidades lentas
Patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 should discuss the risks of thyroid tumors with their healthcare provider
Other Weight Loss Options In addition to Wegovy, there are several weight loss options available to help individuals achieve their weight loss goals